Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
43
ASND Quote, Financials, Valuation and Earnings
Last price:
$136.20
Seasonality move
:
19.34%
Day range:
$135.61 - $141.37
52-week range:
$111.09 - $161.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
21.92x
P/B ratio:
--
Volume:
632.7K
Avg. volume:
509.4K
1-year change:
12.45%
Market cap:
$8.1B
Revenue:
$288.8M
EPS (TTM):
-$8.11
Earnings Data
Next earnings date for ASND
Feb 07
2025
Most recent earnings per share
-$1.89
Missed by $0.32
(Nov 14/2024)
Consensus Estimate
-$1.57
(Nov 14/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ASND Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/07/2025 | Q4 | $101.1M | -- | -- | -$1.39 | -- |
| 11/14/2024 | Q3 | $74M | $63.6M | -$1.89 | -$1.57 | -$0.32 |
| 09/03/2024 | Q2 | $94.2M | $38.8M | -$2.06 | -$1.40 | -$0.65 |
| 05/02/2024 | Q1 | $85.6M | $104.2M | -$2.50 | -$1.52 | -$0.98 |
| 02/07/2024 | Q4 | $92.1M | $148.3M | -$1.66 | -$1.90 | $0.24 |
| 11/07/2023 | Q3 | -- | -- | -$3.14 | -$2.37 | -$0.76 |
| 09/05/2023 | Q2 | -- | -- | -$2.36 | -$2.80 | $0.45 |
| 04/27/2023 | Q1 | -- | -- | -$2.13 | -$2.89 | $0.77 |
| 02/16/2023 | Q4 | -- | -- | -$3.78 | -$2.77 | -$1.02 |
| 11/02/2022 | Q3 | -- | -- | -$3.05 | -$2.52 | -$0.53 |
| 08/10/2022 | Q2 | -- | -- | -$1.56 | -$2.28 | $0.73 |
| 05/11/2022 | Q1 | -- | -- | -$2.48 | -$2.15 | -$0.33 |
| 03/02/2022 | Q4 | -- | -- | -$2.14 | -$2.59 | $0.46 |
| 11/10/2021 | Q3 | -- | -- | -- | -$2.66 | -- |
| 08/25/2021 | Q2 | -- | -- | -$3.01 | -$2.64 | -$0.37 |
| 05/27/2021 | Q1 | -- | -- | -$1.41 | -$2.27 | $0.86 |
| 03/10/2021 | Q4 | -- | -- | -$3.15 | -$1.88 | -$1.27 |
| 11/11/2020 | Q3 | -- | -- | -$2.70 | -$1.87 | -$0.83 |
| 08/27/2020 | Q2 | -- | -- | -$2.17 | -$1.60 | -$0.57 |
| 05/19/2020 | Q1 | -- | -- | -$1.46 | -$1.40 | -$0.05 |
| 12/31/2019 | Q4 | -- | -- | -$1.88 | -$1.32 | -$0.56 |
| 11/18/2019 | Q3 | -- | -- | -$0.59 | -$1.28 | $0.69 |
| 08/28/2019 | Q2 | -- | -- | -- | -$1.33 | -- |
| 04/03/2019 | Q1 | -- | -- | -- | -$1.14 | -- |
| 12/31/2018 | Q4 | -- | -- | -- | -$1.13 | -- |
| 11/28/2018 | Q3 | -- | -- | -- | -$1.20 | -- |
| 08/29/2018 | Q2 | -- | -- | -- | -$0.99 | -- |
| 05/30/2018 | Q1 | -- | -- | -- | -- | -- |
| 03/28/2018 | Q4 | -- | -- | -- | -- | -- |
| 11/16/2017 | Q3 | -- | -- | -- | -- | -- |
| 08/18/2017 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/30/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/31/2016 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -- | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2015 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2014 | Q4 | -- | -- | -- | -- | -- |
Ascendis Pharma AS Earnings Questions
-
How Much did Ascendis Pharma AS Generate in Revenue Last Quarter?
Ascendis Pharma AS reported $63.6M worth of top line sales in its most recent quarter.
-
Did Ascendis Pharma AS Beat Earnings Last Quarter?
Ascendis Pharma AS announced earnings per share of -$1.89 which represents a miss of analyst forecast a -$1.57 per share.
-
Is Ascendis Pharma AS Profitable?
Ascendis Pharma AS reported $51.3M that represents $0.89 per share over the last quarter.
-
What is the Analyst Consensus for Ascendis Pharma AS EPS Next Year?
Ascendis Pharma AS's earnings are forecast to decrease from -$9.26 per share to -$9.46 per share next year representing a decrease of -18.24%.
-
When is Ascendis Pharma AS's Earnings Date?
Ascendis Pharma AS's next earnings date is February 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 7.8% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 11.48% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 2.74% over the past day.
